AMD goes all in on multithreading and extra memory; Intel focuses on specialized cores and overall core counts. Which ...
The demands placed on games and live streams are increasing: players expect responses in a matter of seconds, smooth and ...
What if your storage system could be smarter, faster, and more flexible, without breaking the bank? With the release of Synology DSM 7.3, that vision is closer than ever. This update isn’t just a ...
Apple's newest iPad Pro features the powerful M5 chip and upgraded wireless connectivity, but otherwise remains largely ...
The benchmark results are in. After testing the 2025 MacBook Pro with Apple's M5 CPU, here's my in-depth, side-by-side comparison with last year's M4 MacBook on performance, features, and value.
Apple's M4-powered iPad Pro is a highly capable tablet with an impressive display, leading performance, and enough storage for a lifetime, though iPadOS still has some limitations. Best Deal$1706.8 ...
In a pair of deals, TransCode Therapeutics has bagged Polynoma and its phase 3 cancer vaccine, as well as a $25 million injection into its cash-strapped coffers—but in doing so, the company is trading ...
CK Life Sciences International is set to merge its subsidiary Polynoma with Nasdaq-listed TransCode Therapeutics, in a move expected to boost the pipeline of anticancer drugs, according to the biotech ...
TransCode expands its microRNA-based pipeline with Polynoma's Phase 3-ready seviprotimut-L, a novel polyvalent shed antigen vaccine for the adjuvant treatment of melanoma Philippe Calais, PharmD, PhD, ...
BOSTON - TransCode Therapeutics, Inc. (NASDAQ:RNAZ), a clinical-stage biotech company with a market capitalization of $11.27 million, announced Tuesday the completion of its Phase 1a clinical trial ...
SpaceX has pulled off another successful test flight of Starship, the world’s largest and most powerful rocket. If you're enjoying this article, consider supporting our award-winning journalism by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results